A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.
Wang L, Ke Y, He Q, Paerhati P, Zhuang W, Yue Y, Liu J, Zhang J, Huang L, Yin Q, Zong H, Zhu J, Zhang B.
Wang L, et al. Among authors: huang l.
Theranostics. 2025 Jan 1;15(4):1238-1254. doi: 10.7150/thno.102531. eCollection 2025.
Theranostics. 2025.
PMID: 39816690
Free PMC article.